195 related articles for article (PubMed ID: 12672699)
1. Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion.
Tsuiji H; Takasaki S; Sakamoto M; Irimura T; Hirohashi S
Glycobiology; 2003 Jul; 13(7):521-7. PubMed ID: 12672699
[TBL] [Abstract][Full Text] [Related]
2. Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis.
Ino Y; Gotoh M; Sakamoto M; Tsukagoshi K; Hirohashi S
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):365-70. PubMed ID: 11756660
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.
Nishizawa A; Nakanishi Y; Yoshimura K; Sasajima Y; Yamazaki N; Yamamoto A; Hanada K; Kanai Y; Hirohashi S
Cancer; 2005 Apr; 103(8):1693-700. PubMed ID: 15751018
[TBL] [Abstract][Full Text] [Related]
4. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells.
Huang J; Byrd JC; Yoon WH; Kim YS
Oncol Res; 1992; 4(11-12):507-15. PubMed ID: 1284381
[TBL] [Abstract][Full Text] [Related]
5. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
[TBL] [Abstract][Full Text] [Related]
6. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
Hakomori S
Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the O-glycan elongation limits MUC1 incorporation to cell membrane of human endometrial carcinoma cells.
Porowska H; Paszkiewicz-Gadek A; Anchim T; Wolczynski S; Gindzienski A
Int J Mol Med; 2004 Mar; 13(3):459-64. PubMed ID: 14767580
[TBL] [Abstract][Full Text] [Related]
8. N-glycosylation affects the adhesive function of E-Cadherin through modifying the composition of adherens junctions (AJs) in human breast carcinoma cell line MDA-MB-435.
Zhao H; Liang Y; Xu Z; Wang L; Zhou F; Li Z; Jin J; Yang Y; Fang Z; Hu Y; Zhang L; Su J; Zha X
J Cell Biochem; 2008 May; 104(1):162-75. PubMed ID: 17979184
[TBL] [Abstract][Full Text] [Related]
9. Biphasic effect of cell surface sialic acids on pancreatic cancer cell adhesiveness.
Sawada T; Ho JJ; Sagabe T; Yoon WH; Chung YS; Sowa M; Kim YS
Biochem Biophys Res Commun; 1993 Sep; 195(2):1096-103. PubMed ID: 8373388
[TBL] [Abstract][Full Text] [Related]
10. Benzyl-alpha-GalNAc inhibits sialylation of O-glycosidic sugar chains on CD44 and enhances experimental metastatic capacity in B16BL6 melanoma cells.
Nakano T; Matsui T; Ota T
Anticancer Res; 1996; 16(6B):3577-84. PubMed ID: 9042224
[TBL] [Abstract][Full Text] [Related]
11. Dysadherin expression facilitates cell motility and metastatic potential of human pancreatic cancer cells.
Shimamura T; Yasuda J; Ino Y; Gotoh M; Tsuchiya A; Nakajima A; Sakamoto M; Kanai Y; Hirohashi S
Cancer Res; 2004 Oct; 64(19):6989-95. PubMed ID: 15466191
[TBL] [Abstract][Full Text] [Related]
12. Significance of dysadherin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion.
Maehata Y; Hirahashi M; Aishima S; Kishimoto J; Hirohashi S; Yao T; Takashima H; Tsuneyoshi M; Oda Y
Hum Pathol; 2011 Apr; 42(4):558-67. PubMed ID: 21239043
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of dysadherin and E-cadherin expression in patients with head and neck cancer treated by radiation therapy.
Muramatsu H; Akimoto T; Maebayashi K; Kita M; Mitsuhashi N
Anticancer Res; 2008; 28(6B):3859-64. PubMed ID: 19192641
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of dysadherin expression in patients with non-small cell lung cancer.
Tamura M; Ohta Y; Tsunezuka Y; Matsumoto I; Kawakami K; Oda M; Watanabe G
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):740-5. PubMed ID: 16153922
[TBL] [Abstract][Full Text] [Related]
15. In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin.
Batistatou A; Peschos D; Tsanou H; Charalabopoulos A; Nakanishi Y; Hirohashi S; Agnantis NJ; Charalabopoulos K
Br J Cancer; 2007 May; 96(9):1404-8. PubMed ID: 17437014
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of dysadherin expression in advanced colorectal carcinoma.
Aoki S; Shimamura T; Shibata T; Nakanishi Y; Moriya Y; Sato Y; Kitajima M; Sakamoto M; Hirohashi S
Br J Cancer; 2003 Mar; 88(5):726-32. PubMed ID: 12618882
[TBL] [Abstract][Full Text] [Related]
17. Dysadherin: expression and clinical significance in thyroid carcinoma.
Sato H; Ino Y; Miura A; Abe Y; Sakai H; Ito K; Hirohashi S
J Clin Endocrinol Metab; 2003 Sep; 88(9):4407-12. PubMed ID: 12970317
[TBL] [Abstract][Full Text] [Related]
18. Expression of dysadherin in the human male reproductive tract and in spermatozoa.
Gabrielli NM; Veiga MF; Matos ML; Quintana S; Chemes H; Blanco G; Vazquez-Levin MH
Fertil Steril; 2011 Sep; 96(3):554-561.e2. PubMed ID: 21774927
[TBL] [Abstract][Full Text] [Related]
19. The expression of core fucosylated E-cadherin in cancer cells and lung cancer patients: prognostic implications.
Geng F; Shi BZ; Yuan YF; Wu XZ
Cell Res; 2004 Oct; 14(5):423-33. PubMed ID: 15538974
[TBL] [Abstract][Full Text] [Related]
20. The influence of N- and O-glycosylation inhibitors on the glycosylation profile of cellular membrane proteins and adhesive properties of carcinoma cell lines.
Paszkiewicz-Gadek A; Porowska H; Lemancewicz D; Wolczynski S; Gindzienski A
Int J Mol Med; 2006 Apr; 17(4):669-74. PubMed ID: 16525726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
